Stay updated on Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded navigation/help items No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and a new Intervention/Treatment section, along with a Revision: v3.6.0; removed the old Intervention / Treatment heading and the Revision: v3.5.5.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, signaling an administrative update to the page rather than any changes to the study data.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4 in the metadata. This change does not affect the visible content or how the page operates.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s displayed software/revision version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedThe study condition label was updated from Hepatocellular carcinoma to Adult hepatocellular carcinoma. This clarifies the trial's adult population focus.SummaryDifference0.0%

Stay in the know with updates to Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.